SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

13 Feb 2023 Evaluate
The sales is pegged at Rs. 1726.88 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2002.24 millions during the year-ago period.A good growth in profit of 27.57% reported to Rs. 157.93  millions over Rs. 123.80 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 385.33 millions from 303.76 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1726.88 2002.24 -13.75 5712.77 4841.19 18.00 6855.08 6000.48 14.24
Other Income 110.17 72.48 52.00 358.50 120.89 196.55 187.04 164.43 13.75
PBIDT 385.33 303.76 26.85 1208.58 573.49 110.74 876.78 673.40 30.20
Interest 116.52 64.49 80.68 435.62 235.41 85.05 249.19 325.37 -23.41
PBDT 268.81 239.27 12.35 772.96 338.08 128.63 627.59 343.00 82.97
Depreciation 75.37 67.22 12.12 221.04 197.85 11.72 266.83 192.83 38.38
PBT 193.44 172.05 12.43 551.92 140.23 293.58 360.76 150.17 140.23
TAX 35.51 48.25 -26.40 154.40 39.00 295.90 102.07 67.37 51.51
Deferred Tax -1.23 16.83 -107.31 45.50 13.39 239.81 38.09 39.58 -3.76
PAT 157.93 123.80 27.57 397.52 101.23 292.69 258.69 82.80 212.43
Equity 157.08 127.63 23.07 157.08 127.63 23.07 156.98 127.50 23.12
PBIDTM(%) 22.31 15.17 47.08 21.16 11.85 78.59 12.79 11.22 13.97

Camlin Fine Sciences Share Price

137.85 -2.85 (-2.03%)
23-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2739.00
BASF India 3751.50
Tata Chemicals 730.20
Pidilite Inds. 1566.40
Deepak Nitrite 1637.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: